Next Generation Technology Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
45
- Portfolio
-
22
- Exits
-
17
Next Generation Technology General Information
Description
Founded in 2002, Next Generation Technology is a venture capital firm based in Nazareth, Israel. The firm seeks to invest in innovation-based technologies and entrepreneurs primarily in the life sciences and medical devices.
Contact Information
Website
www.ngt-healthcare2.com
Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Impact Investing
Primary Office
- Wadi El Haj 13
- P.O.Box 1252
- Nazareth 17111
- Israel
+972 00-000-0000
Next Generation Technology Investments (45)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NINA Medical | 22-Aug-2021 | Seed Round | 00000 | Decision/Risk Analysis | Product Development | |
| 000 00000000 | 01-Jun-2021 | 0000 00000 | 00.00 | Surgical Devices | Generating Revenue | 00000 0000000 |
| 00000000 | 26-Nov-2020 | 0000 00000 | 000 | Drug Delivery | Clinical Trials - Phase 1 | |
| 000000 | 01-Jun-2020 | 00000 00000 | 00000 | Clothing | Startup | 00000 0000000 |
| 00000 | 01-Mar-2020 | 0000 00000 | Therapeutic Devices | Generating Revenue | 0000 00000 00.0 | |
| 0000 0000000 | 02-Jun-2019 | 0000 00000 | 00000 | Decision/Risk Analysis | Product Development | |
| 000 00000000 | 01-May-2019 | 0000 00000 | Surgical Devices | Generating Revenue | 00000 0000000 | |
| 0000 00 0000000 | 01-Apr-2019 | 00000 00000 | Surgical Devices | Generating Revenue | 00000 0000000 | |
| EIO Biomedical | 01-Jan-2019 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue | |
| TendoMend | 01-Jan-2019 | Seed Round | 00000 | Surgical Devices | Generating Revenue |
Next Generation Technology Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Implant-B | 23-Apr-2021 | Out of Business | |
| 00000000 | 01-Oct-2020 | 000 00 00000000 | |
| 00000000 | 01-May-2020 | 000 00 00000000 | |
| 0000000 0000000 00 | 23-Sep-2018 | 000000000000000000 | 0000 |
| 0000000000 | 01-Apr-2018 | 000 00 00000000 | |
| 00000 00 | 14-Feb-2018 | 000 | 000.00 |
| 00000000 0000 | 01-Jan-2018 | 000 00 00000000 | |
| 000000000 | 01-Nov-2017 | 000 00 00000000 | |
| MedWell Laboratories | 01-Oct-2017 | Out of Business | |
| Lostam BioPharmaceuticals | 01-Jul-2017 | Out of Business |
Next Generation Technology Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Next Generation Technology Team (7)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Amir Toren Ph.D | Chief Technology Officer & Business Development Director | 0 | 0 | Nazareth, Israel | |
| Tamar Kedar Harris | Executive, Investor Relations | Mississauga, Canada | |||
| Zohar Gendler | Chief Executive Officer & Managing Partner | 00 | 0 | 00 | Nazareth, Israel |
| Nizar Mishael | Managing Partner & CFO | 0 | 0 | Nazareth, Israel |
Next Generation Technology Co-Investors (3)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Israel Innovation Authority | 4 | 0 |
|
|
|
| Intempo Ventures | 0 | 0 |
|
|
|
| Moshe Shoham | 0 |
|
|